A total of 9,975,994 people have already been administered the COVID-19 vaccines Soberana 02, Soberana Plus and Abdala, which means that 90% of the Cuban population is immunized, according to the Ministry of Public Health (MINSAP).

Cuba reported today 49 new COVID-19 cases, 48 hospital discharges and no fatalities.

Cuban President Miguel Díaz-Canel praised today the success of the COVID-19 pediatric immunization program launched in the country in preventing any decease among children and shared the results of a study by the Pedro Kourí Tropical Medicine Institute proving that, during the Omicron surge, the vaccine Soberana was 90.1% effective in the 2 to 5 age group and 95.8% in children between the ages of two and eighteen.

Cuban Minister of Public Health (MINSAP) José Ángel Portal Miranda urged to reinforce prevention and individual responsibility to tackle COVID-19 in light of the slight increase in the infection rate in the last four weeks, including 298 new cases in the past seven days.

COVID-19 transmission in Cuba increase by 83.8 percent up to July 9 after the average of cases per day grew to 41.9 up from 22.8 in June, which triggered the alerts of local authorities.

Cuba studied a total of 1,571 samples for surveillance, 31 of which were positive. The country accumulates 13,989,048 samples taken and 1,106,490 positive.

With the aim of increasing the levels of protection against COVID-19 in the population, the booster vaccination is progressing in Cuba, with a total of 7,420,450 people receiving additional doses.

After undergoing desperation due to acute pain derived from Lithiasis (formation of stony concretions in the urinary tract or gallbladder), Cuban Alfredo Villalon living in this eastern city, praised the benefits of a new local medication to fight that condition, based on Potassium Nitrate and Critic Acid.

Cuba studied a total of 2,021 samples for surveillance, 37 were positive. The country accumulates 13,987,477 samples taken and 1,106,459 positive.

Cuban health ministry ( MINSAP by its Spanish acronym) reported today that 9,975,611 people have completed the anti-COVID-19 vaccination program, with the immunogens developed in the country, Soberana 02, Soberana Plus and Abdala.

Cuban health ministry (MINSAP by its Spanish acronym) reported today that 9,975,414 people (90 %) have completed the anti-COVID-19 vaccination program, with the immunogens developed in the country, Soberana 02, Soberana Plus and Abdala.

Cuban President Miguel Díaz-Canel praised today on Twitter the upcoming start of clinical trials of the national drug against Alzheimer's, NeuralCIM (NeuroEPO) and remarked that Cuban science and innovation continue to contribute to the country's development.

Cuba reported today 43 new COVID-19 cases, 41 hospital discharges and no fatalities.

The Center for Molecular Immunology (CIM) is conducting two clinical trials—named CORVAXCIM and COREPOCIM—on COVID-19 convalescents, according to Sc.D. Mayra Ramos Suzarte, head of CIM’s clinical trials department, who explained that the first of these studies evaluates the safety and effects of the CIMAvax-EGF lung cancer vaccine in convalescents with respiratory disorders after infection by SARS-CoV-2.